SGLT2 inhibitors did not reduce the risk of readmission due to HF (RR = 0.87, 95% CI = 0.58, 1.31; Figure 3), and the statistical heterogeneity was minimal (I2 = 0%). The gene discussed is SLC5A2; the disease is hydrops fetalis.